Clinical Study Site

Hamburg 22763

1 studies enrolling now · 2 studies all time

What they study most

Bleeding, Metastatic Colorectal Cancer (CRC)

Studies at this site

• Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer — Recruiting now
• A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study) — Completed